Arimidex Clinical Trials Arimidex RSS feedThis is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

A Study of Camizestrant in ER+/HER2- Early Breast Cancer After at Least 2 Years of Standard Adjuvant Endocrine Therapy
Condition:   Breast Cancer, Early Breast Cancer Interventions:   Drug: Camizestrant;   Drug: Tamoxifen;   Drug: Anastrozole;   Drug: Letrozole;   Drug: Exemestane Sponsor:   AstraZeneca Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 20, 2023 Category: Research Source Type: clinical trials

Data Analysis for Drug Repurposing for Effective Alzheimer's Medicines (DREAM)- Anastrozole vs Exemestane/Letrozole
Condition:   Breast Cancer Interventions:   Drug: Anastrozole;   Drug: Exemestane/Letrozole Sponsors:   Brigham and Women's Hospital;   National Institute on Aging (NIA);   Rutgers University;   Johns Hopkins University Active, not recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 2, 2022 Category: Research Source Type: clinical trials